|
Atomistry » Fluorine » PDB 3d3e-3du8 » 3du8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 3d3e-3du8 » 3du8 » |
Fluorine in PDB 3du8: Crystal Structure of Gsk-3 Beta in Complex with Nms-869553AEnzymatic activity of Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A
All present enzymatic activity of Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A:
2.7.11.26; Protein crystallography data
The structure of Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A, PDB code: 3du8
was solved by
R.T.Bossi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A
(pdb code 3du8). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A, PDB code: 3du8: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 3du8Go back to Fluorine Binding Sites List in 3du8
Fluorine binding site 1 out
of 2 in the Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 3du8Go back to Fluorine Binding Sites List in 3du8
Fluorine binding site 2 out
of 2 in the Crystal Structure of Gsk-3 Beta in Complex with Nms-869553A
Mono view Stereo pair view
Reference:
M.Menichincheri,
A.Bargiotti,
J.Berthelsen,
J.A.Bertrand,
R.Bossi,
A.Ciavolella,
A.Cirla,
C.Cristiani,
V.Croci,
R.D'alessio,
M.Fasolini,
F.Fiorentini,
B.Forte,
A.Isacchi,
K.Martina,
A.Molinari,
A.Montagnoli,
P.Orsini,
F.Orzi,
E.Pesenti,
D.Pezzetta,
A.Pillan,
I.Poggesi,
F.Roletto,
A.Scolaro,
M.Tato,
M.Tibolla,
B.Valsasina,
M.Varasi,
D.Volpi,
C.Santocanale,
E.Vanotti.
First CDC7 Kinase Inhibitors: Pyrrolopyridinones As Potent and Orally Active Antitumor Agents. 2. Lead Discovery. J.Med.Chem. V. 52 293 2009.
Page generated: Wed Jul 31 18:05:29 2024
ISSN: ISSN 0022-2623 PubMed: 19115845 DOI: 10.1021/JM800977Q |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |